These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases. Na K; Kim HS; Shim HS; Chang JH; Kang SG; Kim SH J Neurooncol; 2019 May; 142(3):445-454. PubMed ID: 30710203 [TBL] [Abstract][Full Text] [Related]
7. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas. Shin H; Sa JK; Bae JS; Koo H; Jin S; Cho HJ; Choi SW; Kyoung JM; Kim JY; Seo YJ; Joung JG; Kim NKD; Son DS; Chung J; Lee T; Kong DS; Choi JW; Seol HJ; Lee JI; Suh YL; Park WY; Nam DH Cancer Res Treat; 2020 Jan; 52(1):41-50. PubMed ID: 31096737 [TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics. Synhaeve NE; van den Bent MJ; French PJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Verdijk R; Dirven CMF; Dubbink HJ Acta Neuropathol Commun; 2018 Nov; 6(1):126. PubMed ID: 30470264 [TBL] [Abstract][Full Text] [Related]
9. Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas: Application of the World Health Organization's 2016 Revised Criteria for Central Nervous System Tumors. Carter JH; McNulty SN; Cimino PJ; Cottrell CE; Heusel JW; Vigh-Conrad KA; Duncavage EJ J Mol Diagn; 2017 Mar; 19(2):328-337. PubMed ID: 28042970 [TBL] [Abstract][Full Text] [Related]
13. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927 [TBL] [Abstract][Full Text] [Related]
14. A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications. Tirrò E; Massimino M; Broggi G; Romano C; Minasi S; Gianno F; Antonelli M; Motta G; Certo F; Altieri R; Manzella L; Caltabiano R; Barbagallo GMV; Buttarelli FR; Magro G; Giangaspero F; Vigneri P Front Oncol; 2022; 12():861078. PubMed ID: 35372034 [TBL] [Abstract][Full Text] [Related]
15. Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations. Parilla M; Kadri S; Patil SA; Fitzpatrick C; Ritterhouse L; Segal J; Collins J; Pytel P J Neuropathol Exp Neurol; 2019 Mar; 78(3):257-267. PubMed ID: 30698790 [TBL] [Abstract][Full Text] [Related]
16. Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas. D'Haene N; Meléndez B; Blanchard O; De Nève N; Lebrun L; Van Campenhout C; Salmon I Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31167453 [TBL] [Abstract][Full Text] [Related]
17. [Classification of gliomas. Current progress and perspectives]. Capper D; Reifenberger G Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization. Sim J; Nam DH; Kim Y; Lee IH; Choi JW; Sa JK; Suh YL Med Oncol; 2018 Mar; 35(5):60. PubMed ID: 29600313 [TBL] [Abstract][Full Text] [Related]
19. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499 [TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study. Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]